NCT05191745

Brief Summary

This is a randomized, double-blind, controlled clinical trial is to evaluate the duration of efficacy of parasternal blocks with the use of local anesthetic adjuncts for analgesia after coronary artery bypass grafting surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at below P25 for phase_3

Timeline
Completed

Started Jan 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 3, 2021

Completed
1 month until next milestone

First Posted

Study publicly available on registry

January 13, 2022

Completed
13 days until next milestone

Study Start

First participant enrolled

January 26, 2022

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 28, 2023

Completed
1.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2024

Completed
Last Updated

June 10, 2024

Status Verified

June 1, 2024

Enrollment Period

1.3 years

First QC Date

December 3, 2021

Last Update Submit

June 6, 2024

Conditions

Keywords

Cardiac surgeryPain

Outcome Measures

Primary Outcomes (1)

  • Pain with inspirometry at 24 hours after surgery

    Numerical Rating Scale (NRS) pain score from the sternotomy site during inspirometry. The VAS score is a scale from 0 to 10 where 0 is equivalent to "no pain" and 10 is equal to "the worst imaginable pain"

    24 hours after surgery

Secondary Outcomes (10)

  • Opioid consumption

    12, 24 and 48 hours after surgery

  • Amount of rescue analgesia administered

    Total in the first 48 hours after surgery

  • Pain score at rest

    12, 24 and 48 hours after surgery

  • Pain score with inspirometry

    12 and 48 hours after surgery

  • Intensive Care Unit (ICU) Length of Stay

    From surgery until discharge from the ICU, assessed from the date of surgery up until 6 months after the completion of the study

  • +5 more secondary outcomes

Other Outcomes (9)

  • Presence of postoperative vomiting

    first 48 hours after surgery

  • Incidence of bradycardia

    first 48 hours after surgery

  • Incidence of hyperglycemia

    first 48 hours after surgery

  • +6 more other outcomes

Study Arms (2)

Intervention group

EXPERIMENTAL

Patients will receive bilateral parasternal blocks at the end of cardiac surgery.

Drug: Parasternal blocks

Control group

PLACEBO COMPARATOR

Patients will receive all standard care as per the hospital protocols.

Drug: Standard of care

Interventions

Parasternal block with Bupivacaine 0.25% + Epinephrine 1:200,000 x 60cc + Dexamethasone 5mg and Dexmedetomidine 50mcg

Also known as: pecto-intercostal fascial blocks
Intervention group

All standard management of postoperative pain, as per local protocols

Control group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients coming for elective and urgent coronary artery bypass (CABG)-only surgery.

You may not qualify if:

  • Patients with a history of regular opioid use.
  • Patients with a history of chronic pain.
  • Patients unable to provide consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Jewish General Hospital

Montreal, Quebec, H3T1E2, Canada

Location

Related Publications (1)

  • Cameron MJ, Long J, Yang SS, Kardash K. How Many Patients Are Needed to Detect a Difference in Pain With Parasternal Blocks? Anesth Analg. 2025 Jul 1;141(1):210-211. doi: 10.1213/ANE.0000000000007355. Epub 2024 Dec 17. No abstract available.

MeSH Terms

Conditions

Pain

Interventions

Standard of Care

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Quality Indicators, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and Evaluation

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

December 3, 2021

First Posted

January 13, 2022

Study Start

January 26, 2022

Primary Completion

April 28, 2023

Study Completion

June 1, 2024

Last Updated

June 10, 2024

Record last verified: 2024-06

Locations